Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| BRSADJ0007 | Other Identifier | OnCore |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To study if Healing Touch is effective during chemotherapy treatment for breast cancer
To study the effectiveness of Healing Touch provided during chemotherapy infusions on the experience of women undergoing treatment for breast cancer. Healing Touch (HT) is a gentle, non-invasive form of energy-balancing work that promotes relaxation and can help manage the side effects of chemotherapy.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Standard Care + Healing Touch (HT) | Experimental | A a gentle, non-invasive form of energy-balancing work that promotes relaxation and can help manage the side effects of chemotherapy. It occurs every other week (during their infusion). |
|
| Standard Care + Guided relaxation | Active Comparator | Guided relaxation every other week (during their infusion). |
|
| standard care only | Active Comparator | Standard care |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Healing Touch | Procedure | every other week (during their infusion) |
| |
| Measure | Description | Time Frame |
|---|---|---|
| FACT-B summary score | Baseline, 6 wks, 14 wks |
| Measure | Description | Time Frame |
|---|---|---|
| Domain scores for FACT-B; BSI-18; FACIT-Fatigue; nausea measured on a Likert scale | Baseline, 6 wks, 14 wks |
Not provided
Inclusion Criteria:- Stage I or II breast cancer
Exclusion Criteria:- Previous chemotherapy exposure
- Concomitant energy-work interventions (HT, Reiki, QiGong, acupuncture).
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Kathy Turner, RN, NP | Stanford University | Principal Investigator |
| Alice "Ellie" Guardino, RN, NP | Stanford University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Stanford University School of Medicine | Stanford | California | 94305 | United States |
Not provided
| ID | Term |
|---|---|
| D001943 | Breast Neoplasms |
| ID | Term |
|---|---|
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D001941 | Breast Diseases |
| D012871 | Skin Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D014110 | Touch |
| D059039 | Standard of Care |
| ID | Term |
|---|---|
| D012677 | Sensation |
| D009424 | Nervous System Physiological Phenomena |
| D055687 | Musculoskeletal and Neural Physiological Phenomena |
| D019984 | Quality Indicators, Health Care |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Standard care |
| Other |
Adriamycin, cyclophosphamide, and paclitaxel administered as standard of care |
|
| guided relaxation | Procedure |
|
| D017437 |
| Skin and Connective Tissue Diseases |
| D011787 | Quality of Health Care |
| D006298 | Health Services Administration |
| D017530 | Health Care Quality, Access, and Evaluation |